Japanese Chemicals Maker AGC to Exit UK Fluoropolymer Site

AGC Chemicals Europe, the European fluorochemicals arm of Japan's AGC Inc., announced on July 13, 2026 that it has opened a consultation with staff over a proposal to cease all production at its Hillhouse manufacturing site in Thornton-Cleveleys, Lancashire. The proposal covers every role at the plant, affecting approximately 190 permanent employees and 18 agency workers. The consultation is expected to run for at least 45 days, and if the proposal is confirmed, production would stop by the end of 2026.

The company attributed the decision to four consecutive years of financial losses at the site, citing a volatile and highly competitive market despite continued investment from the parent group. AGC has stressed that no final decision has been taken and that it will work with unions and employee representatives on ways to avoid or reduce dismissals.

The closure proposal is unfolding alongside a separate environmental dispute. Fluoropolymer manufacturing at Hillhouse dates back to 1952, when the site was part of the former ICI complex. AGC acquired the operation in 1999. The plant used perfluorooctanoic acid, known as PFOA, as a processing aid for polytetrafluoroethylene until 2012. Local investigations estimate that around 49 tonnes of PFOA were released from the site between the 1950s and 2012. PFOA was banned globally in 2020 and belongs to the group of long-lived fluorinated substances often described as forever chemicals.

A multi-agency investigation led by the Environment Agency and Wyre Council began in 2024. Soil and produce testing found widespread contamination in the surrounding area. Residents have been advised to wash and peel homegrown vegetables and to avoid eating locally produced eggs, and two allotment sites near the plant have been closed. As of mid-July 2026, more than 60 residents have instructed law firm Leigh Day to explore a group legal claim against the company over PFAS contamination linked to the Hillhouse Enterprise Zone.

On July 16, 2026, three days after the closure announcement, AGC Chemicals Europe stated publicly that a decision to stop production would not affect the ongoing contamination investigation. The company said it remains committed to its environmental permit obligations and to any environmental monitoring that may be required. Wyre Council confirmed the same day that the regulatory process is continuing unchanged and that it is monitoring the situation. Available health monitoring data is not currently sufficient to establish a direct causal link between the historical emissions and specific health outcomes in the community.

The supply chain consequences reach well beyond Lancashire. Hillhouse is one of the few remaining fluoropolymer production sites in Europe and produces the Fluon range of PTFE, ETFE and PFA resins along with AFLAS fluoroelastomers. AGC describes itself as the global leader in ETFE, and a dedicated ETFE unit was commissioned at Thornton-Cleveleys in 2007 to expand group capacity. ETFE resin and film are used in aerospace and rail wire insulation, architectural membranes and facades, release films for semiconductor and printed circuit board manufacturing, photovoltaic backsheets and agricultural greenhouse films. PTFE and PFA from the site feed seals, linings, coatings and process tubing across the chemical, pharmaceutical and semiconductor industries.

The timing compounds an already tight European supply picture. 3M completed its exit from all fluoropolymer manufacturing at the end of 2025, removing the Dyneon portfolio from the market. Voluntary PFAS phase-outs by other suppliers have already led to PTFE line shutdowns in Europe. In parallel, the European Chemicals Agency closed its public consultation on the proposed EU-wide PFAS restriction on May 25, 2026. The Risk Assessment Committee published its final opinion and the Socio-Economic Analysis Committee its draft opinion on March 26, 2026, and both support a restriction covering more than 10,000 substances. Requests to exclude fluoropolymers entirely from the scope were not accepted, although an expanded derogation framework was introduced. Industry reporting in July 2026 describes the steepest PTFE cost pressures in several years.

Switching suppliers is not a short-term option for most buyers. Qualification of a new fluoropolymer grade in aerospace, medical device or semiconductor applications typically requires 12 to 24 months of material testing, product validation and regulatory review. That qualification lead time, rather than raw physical capacity elsewhere, is the binding constraint. In the near term, European processors and distributors are expected to place last-time-buy orders ahead of any shutdown, which will inflate demand and lengthen lead times at the remaining producers through the fourth quarter of 2026 and into 2027.

Over the medium term, volume is likely to shift toward Chemours, Syensqo, Daikin, Gujarat Fluorochemicals and Chinese producers such as Dongyue and Juhua. That shift would deepen European import dependence for materials used in defence, aerospace and semiconductor manufacturing, an outcome that carries clear strategic autonomy implications for Brussels. Price increases are expected to be most pronounced on specialty ETFE grades and AFLAS, where the global supplier base is narrowest, and more moderate on PTFE, where Asian supply is deeper.

Two questions will determine how the situation develops. The first is how responsibility for remediating historical contamination at the site will be allocated and funded once production ends. The second is whether AGC transfers the specialty fluoropolymer capacity at Hillhouse to other group sites in Japan or the United States, or simply retires it. The consultation period runs into late August 2026, and no confirmed decision is expected before then.

The broader signal for the sector is that environmental liability has become an independent driver of capacity exit in European fluorochemicals, operating alongside regulatory pressure rather than as a consequence of it. Other European fluorinated production sites facing similar historical contamination claims are now exposed to the same combination of remediation cost, litigation risk and margin compression.